Viewing Study NCT03801434


Ignite Creation Date: 2025-12-25 @ 2:32 AM
Ignite Modification Date: 2026-02-06 @ 12:26 AM
Study NCT ID: NCT03801434
Status: RECRUITING
Last Update Posted: 2025-12-23
First Post: 2019-01-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders
Sponsor: William Shomali
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module